Welcome to our dedicated page for Aesthetic Medical International Holdings Group Ltd. American Depositary Shares SEC filings (Ticker: AIH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Aesthetic Medical International Holdings Group Ltd. American Depositary Shares's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Aesthetic Medical International Holdings Group Ltd. American Depositary Shares's regulatory disclosures and financial reporting.
Aesthetic Medical International reported operational shifts in the first half of 2025: total treatment cases fell by 2.3% year‑on‑year following reduced advertising spend, while the mix moved toward non‑surgical aesthetic procedures, which rose by 3.6 percentage points as a share of total treatments. Average spending per customer declined 1.2%, from RMB1,099 to RMB1,086, driven by increased promotional activity such as discounted live‑stream e‑commerce offers. The disclosure includes references to standard financial line items and balance sheet headings but lacks complete numeric tables or full financial results in the provided extract.